Skip to main content

Advertisement

Table 2 Baseline characteristics of the subjects according to follow-up outcomes

From: The fatty liver index (FLI) and incident hypertension: a longitudinal study among Chinese population

Variables Subjects developed HTN (n = 2047) Subjects did not develop HTN (n = 2639) P
Gender (male/female, n) 1541/506 1636/1003 <  0.001
Age (years) 44.0(36.0–54.0) 38.0(33.0–46.0) <  0.001
BMI (kg/m2) 23.6(21.8–25.4) 21.7(19.8–23.6) <  0.001
SBP (mmHg) 124.0(117.0–131.0) 112.0(105.0–120.0) <  0.001
DBP (mmHg) 80.0(75.0–84.0) 71.0(67.0–76.0) <  0.001
WC (cm) 81.0(75.0–87.0) 75.0(69.0–81.0) <  0.001
FLI 22.0(9.2–41.6) 8.03(3.63–19.96) <  0.001
BUN (μmol/L) 5.09(4.29–5.96) 4.86(4.15–5.66) <  0.001
Cr (μmol/L) 74.0(64.0–83.0) 71.0(60.0–80.0) <  0.001
FPG (mmol/L) 4.53(4.21–4.89) 4.37(4.09–4.66) <  0.001
UA (μmol/L) 342.0(284.0–395.0) 306.0(250.0–364.0) <  0.001
AST (U/L) 20.0(17.0–25.0) 19.0(16.0–23.0) <  0.001
ALT (U/L) 25.0(17.0–37.0) 20.0(15.0–30.0) <  0.001
y-GGT (U/L) 21.0(15.0–34.0) 16.0(11.0–24.0) <  0.001
TC (mmol/L) 4.83(4.28–5.50) 4.56(3.99–5.14) <  0.001
TG (mmol/L) 1.38(1.01–2.02) 1.07(0.80–1.51) <  0.001
HDL-C (mmol/L) 1.26(1.07–1.52) 1.27(1.08–1.58) 0.020
LDL-C (mmol/L) 2.73(2.24–3.29) 2.51(2.04–3.03) <  0.001
Apo-A1 (g/L) 1.29(1.13–1.50) 1.30(1.13–1.48) 0.815
Apo-B (g/L) 0.97(0.81–1.14) 0.85(0.71–1.01) <  0.001
eGFR (mL/(min·1.73 m2)) 108.0(95.0–122.0) 111.6(100.2–126.2) <  0.001